Detalhe da pesquisa
1.
Bioisosteric Design Identifies Inhibitors of Mycobacterium tuberculosis DNA Gyrase ATPase Activity.
J Chem Inf Model
; 63(9): 2707-2718, 2023 05 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37074047
2.
Identification of Potent DNA Gyrase Inhibitors Active against Mycobacterium tuberculosis.
J Chem Inf Model
; 62(7): 1680-1690, 2022 04 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35347987
3.
Virtual Screening Identifies Novel and Potent Inhibitors of Mycobacterium tuberculosis PknB with Antibacterial Activity.
J Chem Inf Model
; 62(24): 6508-6518, 2022 12 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35994014
4.
Discovery of New and Potent InhA Inhibitors as Antituberculosis Agents: Structure-Based Virtual Screening Validated by Biological Assays and X-ray Crystallography.
J Chem Inf Model
; 60(1): 226-234, 2020 01 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-31820972
5.
Mycobacterium haemophilum scleritis: two case reports and review of literature.
BMC Ophthalmol
; 20(1): 378, 2020 Sep 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-32967654
6.
Potent activity against multidrug-resistant Mycobacterium tuberculosis of α-mangostin analogs.
Chem Pharm Bull (Tokyo)
; 61(2): 194-203, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23150066
7.
UHPLC-QQQ-MS and RP-HPLC Detection of Bioactive Alizarin and Scopoletin Metabolites from Morinda citrifolia Root Extracts and Their Antitubercular, Antibacterial, and Antioxidant Activities.
ACS Omega
; 8(32): 29615-29624, 2023 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37599981
8.
Antimycobacterial activity of bisbenzylisoquinoline alkaloids from Tiliacora triandra against multidrug-resistant isolates of Mycobacterium tuberculosis.
Bioorg Med Chem Lett
; 22(8): 2902-5, 2012 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22418278
9.
In Vitro Activities of Enantiopure and Racemic 1'-Acetoxychavicol Acetate against Clinical Isolates of Mycobacterium tuberculosis.
Sci Pharm
; 85(3)2017 Sep 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-28927024
10.
Antimycobacterial activity of natural products and synthetic agents: pyrrolodiquinolines and vermelhotin as anti-tubercular leads against clinical multidrug resistant isolates of Mycobacterium tuberculosis.
Eur J Med Chem
; 89: 1-12, 2015 Jan 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-25462220
11.
Concurrent chromomycosis and aspergillosis of the maxillary sinus.
J Med Assoc Thai
; 87(9): 1112-5, 2004 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-15516015
12.
Cutaneous Mycobacterium haemophilum infections in immunocompromised patients in a tertiary hospital in Bangkok, Thailand: under-reported/under-recognized infection.
JMM Case Rep
; 1(4): e002618, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28663805
13.
Isoxazole analogs of curcuminoids with highly potent multidrug-resistant antimycobacterial activity.
Eur J Med Chem
; 45(10): 4446-57, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20691508
14.
In vitro activities of cloxyquin (5-chloroquinolin-8-ol) against Mycobacterium tuberculosis.
Antimicrob Agents Chemother
; 51(3): 1105-6, 2007 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-17178795
15.
In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.
Antimicrob Agents Chemother
; 49(4): 1447-54, 2005 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-15793125